Aldeyra Therapeutics completes enrollment in part 1 of phase 3 study of eye disorder drug
05 January 2022 - 3:50AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Apr 2023 to Apr 2024